Now showing items 1-1 of 1

    • The Role of PI3K in Met Driven Cancer: A Recap. 

      Hervieu, A; Kermorgant, S (2018)
      The Receptor Tyrosine Kinase (RTK) Met, overexpressed or mutated in cancer, plays a major role in cancer progression and represents an attractive target for cancer therapy. However RTK inhibitors can lead to drug resistance, ...